The capacity for sustained self-renewal is one of the defining features of hematopoietic stem cells (HSCs). However, the molecular bases for HSC self-renewal remain obscure. We have previously reported that HSC expansion is profoundly affected by Hoxb4 overexpression and more recently developed HOXB4- based reagents and strategies which provide tools for deepening our knowledge of self-renewal mechanisms, and for achievement of clinically useful levels of HSC expansion.
Four aims are proposed in this first renewal application: 1-To enhance the potential of HSCs to expand in vitro. This will be investigated first by varying Hoxb4 and Pbxl levels in HSCs as recently reported with our in vivo studies and by testing novel Hox-containing fusion genes with enhanced potential for HSC expansion. The contribution of growth factors and precursor differentiation stage (e.g., HSC vs MPP, etc) to HOXB4-driven HSC expansion will also be assessed. 2-To develop and test clinically-relevant strategies aimed at achieving a maximal expansion of HSCs in vitro. This includes the generation of soluble reagents that will interfere with the function of PBX1 and by testing the function of stabilized HOXB4 proteins. Studies with human HSCs will be conducted and effects of the manipulation evaluated by xenotransplantation using NOD/SCID mice and fetal sheep as recipients. 3-To identify a HOXB4-containing """"""""HSC-self-renewal protein complex"""""""" and determine the role of the newly identified proteins in HSC self-renewal. Strategies include the utilization of a functional tandem affinity purification (TAP)-tagged HOXB4 and isolation of the complex in relevant cells. Identified proteins will be functionally validated using RNA interference. 4-To identify target genes to HOXB4 in purified mouse HSCs.
This aim combines cell purification of newly characterized HSC populations with microarray analysis from small cell numbers and preliminary target gene validation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL065430-09
Application #
7404385
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Thomas, John
Project Start
2000-07-01
Project End
2010-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
9
Fiscal Year
2008
Total Cost
$345,939
Indirect Cost
Name
University of Montreal
Department
Type
DUNS #
207622838
City
Montreal
State
PQ
Country
Canada
Zip Code
H3 3-J7
Sekulovic, Sanja; Gasparetto, Maura; Lecault, Veronique et al. (2011) Ontogeny stage-independent and high-level clonal expansion in vitro of mouse hematopoietic stem cells stimulated by an engineered NUP98-HOX fusion transcription factor. Blood 118:4366-76
Sekulovic, Sanja; Gylfadottir, Vala; Vulto, Irma et al. (2011) Prolonged self-renewal activity unmasks telomerase control of telomere homeostasis and function of mouse hematopoietic stem cells. Blood 118:1766-73
Cellot, Sonia; Krosl, Jana; Chagraoui, Jalila et al. (2007) Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells. Exp Hematol 35:802-16
Ohta, Hideaki; Sekulovic, Sanja; Bakovic, Silvia et al. (2007) Near-maximal expansions of hematopoietic stem cells in culture using NUP98-HOX fusions. Exp Hematol 35:817-30
Krosl, Jana; Beslu, Nathalie; Mayotte, Nadine et al. (2003) The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18:561-71
Buske, Christian; Feuring-Buske, Michaela; Abramovich, Carolina et al. (2002) Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells. Blood 100:862-8
Antonchuk, Jennifer; Sauvageau, Guy; Humphries, R Keith (2002) HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 109:39-45
Abramovich, Carolina; Chavez, Elizabeth A; Lansdorp, Peter M et al. (2002) Functional characterization of multiple domains involved in the subcellular localization of the hematopoietic Pbx interacting protein (HPIP). Oncogene 21:6766-71